Gene · 5394
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoantibodies against PIP4K2B and AKT3 Are Associated with Skin and Lung Fibrosis in Patients with Systemic Sclerosis. | Int J Mol Sci | 2023 | 36982700 | PubTator, text mining | PubMed |
| Immune Checkpoint Inhibitor Related Rheumatological Complications: Cooperation between Rheumatologists and Oncologists. | Int J Environ Res Public Health | 2023 | 36981837 | PubTator, text mining | PubMed |
| Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review. | Cancers (Basel) | 2023 | 36980718 | PubTator, text mining | PubMed |
| Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features. | BMC Musculoskelet Disord | 2023 | 36959614 | PubTator, text mining | PubMed |
| First-degree relatives of patients with systemic lupus erythematosus: Autoreactivity but not autoimmunity? | Int J Rheum Dis | 2023 | 36942901 | PubTator, text mining | PubMed |
| BESST: a novel LncRNA knockout strategy with less genome perturbance. | Nucleic Acids Res | 2023 | 36938886 | PubTator, text mining | PubMed |
| Extensive cardiac FDG uptake in a patient with AL amyloidosis. | J Nucl Cardiol | 2023 | 36930456 | PubTator, text mining | PubMed |
| Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy. | J Clin Neurol | 2023 | 36929062 | PubTator, text mining | PubMed |
| RNA helicase MTR4 drives tumorigenesis of nasopharyngeal carcinoma by regulating the expression of key cell cycle genes. | Protein Cell | 2023 | 36929008 | PubTator, text mining | PubMed |
| COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report. | Immunol Res | 2023 | 36928720 | PubTator, text mining | PubMed |
| Inactivation of Exosc10 in the oocyte impairs oocyte development and maturation, leading to a depletion of the ovarian reserve in mice. | Int J Biol Sci | 2023 | 36923944 | PubTator, text mining | PubMed |
| Inflammatory myopathies and beyond: The dual role of neutrophils in muscle damage and regeneration. | Front Immunol | 2023 | 36923415 | PubTator, text mining | PubMed |
| The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing. | Nucleic Acids Res | 2023 | 36912080 | Swiss-Prot, curated | PubMed |
| Post-Transcriptional and Post-Translational Modifications in Telomerase Biogenesis and Recruitment to Telomeres. | Int J Mol Sci | 2023 | 36902458 | PubTator, text mining | PubMed |
| Conserved Transcriptome Features Define Prepubertal Primate Spermatogonial Stem Cells as Adark Spermatogonia and Identify Unique Regulators. | Int J Mol Sci | 2023 | 36902187 | PubTator, text mining | PubMed |
| Advanced Autoantibody Testing in Systemic Sclerosis. | Diagnostics (Basel) | 2023 | 36899995 | PubTator, text mining | PubMed |
| Statin-Induced Immune-Mediated Necrotizing Myopathy Resulting in Proximal Muscle Weakness. | J Med Cases | 2023 | 36896367 | PubTator, text mining | PubMed |
| Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension. | Arthritis Res Ther | 2023 | 36895026 | PubTator, text mining | PubMed |
| Muscle pathology of antisynthetase syndrome according to antibody subtypes. | Brain Pathol | 2023 | 36882048 | PubTator, text mining | PubMed |
| LncRNA HOTAIRM1 functions in DNA double-strand break repair via its association with DNA repair and mRNA surveillance factors. | Nucleic Acids Res | 2023 | 36881772 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5394/papers?page=9